Mastitis Market Research Report Information by Type (Bovine {Contagious Mastitis, Environmental Mastitis and Opportunist Mastitis} and Human {Non-Infectious Mastitis and Infectious Mastitis}), Treatment (Bovine {Antibiotics and Vaccines} and Human {Pain Relievers and Antibiotics}), End User (Veterinary Centers and Hospital & Clinics) - Forecast till 2032

1 Report Prologue

2 Market Introduction

2.1 Definition 19

2.2 Scope of the Study 19

2.3 Research Objective 19

2.4 Assumptions & Limitations 19

2.4.1 Assumptions 19

2.4.2 Limitations 19

2.4.3 Market Structure 20

3 Research Methodology

3.1 Primary Research Methodology 22

3.2 Secondary Research Methodology 24

3.3 Market Size Estimation 25

3.4 Forecast Model 25

4 Market Dynamics

4.1 Introduction 27

4.2 Drivers 28

4.2.1 Rising Cases of Breast Cancer 28

4.2.2 Increasing Rate of Pregnancy 28

4.2.3 Unhygienic Barn Conditions Causing Contagious Mastitis in Bovines 28

4.3 Restraints 29

4.3.1 Lack of Awareness 29

4.3.2 Complications in Diagnosis due to Similar Symptoms of Breast Cancer & Mastitis 29

4.4 Opportunity 29

4.4.1 Entering Developing Economies 29

4.5 Macroeconomics 29

4.5.1 Trends in Mastitis 30

5 Market Factor Analysis

5.1 Porter’s Five Forces Model 32

5.1.1 Bargaining Power of Suppliers 32

5.1.2 Bargaining Power of Buyers 33

5.1.3 Threat of New Entrants 33

5.1.4 Threat of Substitutes 33

5.1.5 Intensity of Rivalry 33

5.2 Value Chain Analysis 34

5.2.1 R&D & Designing 34

5.2.2 Manufacturing 34

5.2.3 Distribution & Sales 34

5.2.4 Post-Sales Services 34

5.3 Investment Opportunities 35

5.4 Price Analysis 35

6 Global Mastitis Market, By Type

6.1 Introduction 37

6.2 Bovine 38

6.2.1 Contagious Mastitis 38

6.2.2 Environmental Mastitis 39

6.2.3 Opportunist Mastitis 39

6.3 Human 40

6.3.1 Non-Infectious Mastitis 40

6.3.2 Infectious Mastitis 41

7 Global Mastitis Market, By Treatment

7.1 Introduction 43

7.2 Bovine 44

7.2.1 Antibiotics 44

7.2.2 Vaccines 44

7.3 Human 45

7.3.1 Pain Relievers 45

7.3.2 Antibiotics 45

8 Global Mastitis Market, By End User

8.1 Introduction 47

8.2 Veterinary Centers 48

8.3 Hospital & Clinics 48

9 Global Mastitis Market, By Region

9.1 Introduction 50

9.2 Americas 51

9.2.1 North America 54

9.2.1.1 US 56

9.2.1.2 Canada 58

9.2.2 South America 60

9.3 Europe 62

9.3.1 Western Europe 64

9.3.1.1 Germany 67

9.3.1.2 France 69

9.3.1.3 UK 71

9.3.1.4 Italy 73

9.3.1.5 Spain 75

9.3.1.6 Rest of Western Europe 77

9.3.2 Eastern Europe 79

9.4 Asia-Pacific 81

9.4.1 Japan 83

9.4.2 China 85

9.4.3 India 87

9.4.4 Australia 89

9.4.5 South Korea 91

9.4.6 Rest of Asia-Pacific 93

9.5 Middle East & Africa 95

9.5.1 Saudi Arabia 97

9.5.2 United Arab Emirates 99

9.5.3 Kuwait 101

9.5.4 Oman 103

9.5.5 Qatar 105

9.5.6 Rest of Middle East 107

10 Competitive Landscape

10.1 Competitive Scenario 110

10.1.1 Introduction 110

11 Company Profiles

11.1 Bayer AG 113

11.1.1 Company Overview 113

11.1.2 Financial Overview 113

11.1.3 Products Offering 114

11.1.4 Key Developments 114

11.1.5 SWOT Analysis 114

11.1.6 Key Strategy 114

11.2 BioNumerik Pharmaceuticals Inc 115

11.2.1 Company Overview 115

11.2.2 Financial Overview 115

11.2.3 Products/Services Offered 115

11.2.4 Key Developments 115

11.2.5 SWOT Analysis 116

11.2.6 Key Strategy 116

11.3 Oncothyreon Inc 117

11.3.1 Company Overview 117

11.3.2 Financial Overview 117

11.3.3 Products/Services Offered 117

11.3.4 Key Developments 117

11.3.5 SWOT Analysis 118

11.3.6 Key Strategy 118

11.4 Oncogenex 119

11.4.1 Company Overview 119

11.4.2 Financial Overview 119

11.4.3 Products/Services Offered 119

11.4.4 Key Developments 119

11.4.5 SWOT Analysis 119

11.4.6 Key Strategy 120

11.5 Apthera Inc. 121

11.5.1 Company Overview 121

11.5.2 Financial Overview 121

11.5.3 Products/Services Offered 121

11.5.4 Key Developments 121

11.5.5 SWOT Analysis 121

11.5.6 Key Strategy 122

11.6 Zoetis Inc 123

11.6.1 Company Overview 123

11.6.2 Financial Overview 123

11.6.3 Products/Services Offered 124

11.6.4 Key Developments 124

11.6.5 SWOT Analysis 124

11.6.6 Key Strategy 124

11.7 Boehringer Ingelheim GmbH 125

11.7.1 Company Overview 125

11.7.2 Financial Overview 125

11.7.3 Products/Services Offered 126

11.7.4 Key Developments 126

11.7.5 SWOT Analysis 126

11.7.6 Key Strategy 126

11.8 Merck Co. & Inc 127

11.8.1 Company Overview 127

11.8.2 Financial Overview 127

11.8.3 Products/Services Offered 128

11.8.4 Key Developments 128

11.8.5 SWOT Analysis 128

11.8.6 Key Strategy 128

11.9 Astellas Pharma Inc 129

11.9.1 Company Overview 129

11.9.2 Financial Overview 129

11.9.3 Products/Services Offered 130

11.9.4 Key Developments 130

11.9.5 SWOT Analysis 130

11.9.6 Key Strategy 130

11.10 Pfizer Inc. 131

11.10.1 Company Overview 131

11.10.2 Financial Overview 131

11.10.3 Products/Services Offered 132

11.10.4 Key Developments 132

11.10.5 SWOT Analysis 132

11.10.6 Key Strategy 132

11.11 Novartis AG 133

11.11.1 Company Overview 133

11.11.2 Financial Overview 133

11.11.3 Products/Services Offered 134

11.11.4 Key Developments 134

11.11.5 SWOT Analysis 134

11.11.6 Key Strategy 134

11.12 Sanofi SA 135

11.12.1 Company Overview 135

11.12.2 Financial Overview 135

11.12.3 Products/Services Offered 136

11.12.4 Key Developments 136

11.12.5 SWOT Analysis 136

11.12.6 Key Strategy 136

11.13 F. Hoffmann-La Roche AG 137

11.13.1 Company Overview 137

11.13.2 Financial Overview 137

11.13.3 Products/Services Offered 138

11.13.4 Key Developments 138

11.13.5 SWOT Analysis 138

11.13.6 Key Strategy 138

12 Appendix

12.1 Discussion Blue Print 140

12.2 References 141

13 List of Tables

TABLE 1 MARKET SYNOPSIS 17

TABLE 2 PRIMARY INTERVIEWS 23

TABLE 3 GLOBAL MASTITIS MARKET, BY TYPE 2020–2027 (USD MILLION) 37

TABLE 4 GLOBAL MASTITIS MARKET FOR BOVINE, BY TYPE 2020–2027 (USD MILLION) 38

TABLE 5 GLOBAL MASTITIS MARKET FOR BOVINE, BY REGION 2020–2027 (USD MILLION) 38

TABLE 6 GLOBAL MASTITIS MARKET FOR CONTAGIOUS MASTITIS, BY REGION 2020–2027 (USD MILLION) 38

TABLE 7 GLOBAL MASTITIS MARKET FOR ENVIRONMENTAL MASTITIS, BY REGION 2020–2027 (USD MILLION) 39

TABLE 8 GLOBAL MASTITIS MARKET FOR OPPORTUNIST MASTITIS, BY REGION 2020–2027 (USD MILLION) 39

TABLE 9 GLOBAL MASTITIS MARKET FOR HUMAN, BY TYPE 2020–2027 (USD MILLION) 40

TABLE 10 GLOBAL MASTITIS MARKET FOR HUMAN, BY REGION 2020–2027 (USD MILLION) 40

TABLE 11 GLOBAL MASTITIS MARKET FOR NON–INFECTIOUS MASTITIS, BY REGION 2020–2027 (USD MILLION) 40

TABLE 12 GLOBAL MASTITIS MARKET FOR INFECTIOUS MASTITIS, BY REGION 2020–2027 (USD MILLION) 41

TABLE 13 GLOBAL MASTITIS MARKET, BY TREATMENT 2020–2027 (USD MILLION) 43

TABLE 14 GLOBAL MASTITIS MARKET FOR BOVINE, BY TREATMENT TYPE 2020–2027 (USD MILLION) 44

TABLE 15 GLOBAL MASTITIS MARKET FOR ANTIBIOTICS, BY REGION TYPE 2020–2027 (USD MILLION) 44

TABLE 16 GLOBAL MASTITIS MARKET FOR VACCINES, BY REGION 2020–2027 (USD MILLION) 44

TABLE 17 GLOBAL MASTITIS MARKET FOR HUMAN, BY TREATMENT TYPE 2020–2027 (USD MILLION) 45

TABLE 18 GLOBAL MASTITIS MARKET FOR PAIN RELIEVERS, BY REGION TYPE 2020–2027 (USD MILLION) 45

TABLE 19 GLOBAL MASTITIS MARKET FOR ANTIBIOTICS, BY REGION 2020–2027 (USD MILLION) 45

TABLE 20 GLOBAL MASTITIS MARKET, BY END–USER 2020–2027 (USD MILLION) 47

TABLE 21 GLOBAL MASTITIS MARKET FOR VETERINARY CENTRES, BY REGION 2020–2027 (USD MILLION) 48

TABLE 22 GLOBAL MASTITIS MARKET FOR HOSPITAL & CLINICS, BY REGION 2020–2027 (USD MILLION) 48

TABLE 23 GLOBAL MASTITIS MARKET, BY REGION 2020–2027 (USD MILLION) 51

TABLE 24 AMERICAS MASTITIS MARKET, BY REGION 2020–2027 (USD MILLION) 51

TABLE 25 AMERICAS MASTITIS MARKET, BY TYPE 2020–2027 (USD MILLION) 52

TABLE 26 AMERICAS MASTITIS MARKET FOR BOVINE, BY TYPE 2020–2027 (USD MILLION) 52

TABLE 27 AMERICAS MASTITIS MARKET FOR HUMAN, BY TYPE 2020–2027 (USD MILLION) 52

TABLE 28 AMERICAS MASTITIS MARKET, BY TREATMENT 2020–2027 (USD MILLION) 52

TABLE 29 AMERICAS MASTITIS MARKET FOR BOVINE, BY TREATMENT TYPE 2020–2027 (USD MILLION) 53

TABLE 30 AMERICAS MASTITIS MARKET FOR HUMAN, BY TREATMENT TYPE 2020–2027 (USD MILLION) 53

TABLE 31 AMERICAS MASTITIS MARKET, BY END–USER 2020–2027 (USD MILLION) 53

TABLE 32 NORTH AMERICA MASTITIS MARKET, BY COUNTRY 2020–2027 (USD MILLION) 54

TABLE 33 NORTH AMERICA MASTITIS MARKET, BY TYPE 2020–2027 (USD MILLION) 54

TABLE 34 NORTH AMERICA MASTITIS MARKET FOR BOVINE, BY TYPE 2020–2027 (USD MILLION) 54

TABLE 35 NORTH AMERICA MASTITIS MARKET FOR HUMAN, BY TYPE 2020–2027 (USD MILLION) 55

TABLE 36 NORTH AMERICA MASTITIS MARKET, BY TREATMENT 2020–2027 (USD MILLION) 55

TABLE 37 NORTH AMERICA MASTITIS MARKET FOR BOVINE, BY TREATMENT TYPE 2020–2027 (USD MILLION) 55

TABLE 38 NORTH AMERICA MASTITIS MARKET FOR HUMAN, BY TREATMENT TYPE 2020–2027 (USD MILLION) 55

TABLE 39 NORTH AMERICA MASTITIS MARKET, BY END–USER 2020–2027 (USD MILLION) 56

TABLE 40 US MASTITIS MARKET, BY TYPE 2020–2027 (USD MILLION) 56

TABLE 41 US MASTITIS MARKET FOR BOVINE, BY TYPE 2020–2027 (USD MILLION) 56

TABLE 42 US MASTITIS MARKET FOR HUMAN, BY TYPE 2020–2027 (USD MILLION) 56

TABLE 43 US MASTITIS MARKET, BY TREATMENT 2020–2027 (USD MILLION) 57

TABLE 44 US MASTITIS MARKET FOR BOVINE, BY TREATMENT TYPE 2020–2027 (USD MILLION) 57

TABLE 45 US MASTITIS MARKET FOR HUMAN, BY TREATMENT TYPE 2020–2027 (USD MILLION) 57

TABLE 46 US MASTITIS MARKET, BY END–USER 2020–2027 (USD MILLION) 57

TABLE 47 CANADA MASTITIS MARKET, BY TYPE 2020–2027 (USD MILLION) 58

TABLE 48 CANADA MASTITIS MARKET FOR BOVINE, BY TYPE 2020–2027 (USD MILLION) 58

TABLE 49 CANADA MASTITIS MARKET FOR HUMAN, BY TYPE 2020–2027 (USD MILLION) 58

TABLE 50 CANADA MASTITIS MARKET, BY TREATMENT 2020–2027 (USD MILLION) 58

TABLE 51 CANADA MASTITIS MARKET FOR BOVINE, BY TREATMENT TYPE 2020–2027 (USD MILLION) 59

TABLE 52 CANADA MASTITIS MARKET FOR HUMAN, BY TREATMENT TYPE 2020–2027 (USD MILLION) 59

TABLE 53 CANADA MASTITIS MARKET, BY END–USER 2020–2027 (USD MILLION) 59

TABLE 54 SOUTH AMERICA MASTITIS MARKET, BY TYPE 2020–2027 (USD MILLION) 60

TABLE 55 SOUTH AMERICA MASTITIS MARKET FOR BOVINE, BY TYPE 2020–2027 (USD MILLION) 60

TABLE 56 SOUTH AMERICA MASTITIS MARKET FOR HUMAN, BY TYPE 2020–2027 (USD MILLION) 60

TABLE 57 SOUTH AMERICA MASTITIS MARKET, BY TREATMENT 2020–2027 (USD MILLION) 60

TABLE 58 SOUTH AMERICA MASTITIS MARKET FOR BOVINE, BY TREATMENT TYPE 2020–2027 (USD MILLION) 61

TABLE 59 SOUTH AMERICA MASTITIS MARKET FOR HUMAN, BY TREATMENT TYPE 2020–2027 (USD MILLION) 61

TABLE 60 SOUTH AMERICA MASTITIS MARKET, BY END–USER 2020–2027 (USD MILLION) 61

TABLE 61 EUROPE MASTITIS MARKET, BY REGION 2020–2027 (USD MILLION) 62

TABLE 62 EUROPE MASTITIS MARKET, BY TYPE 2020–2027 (USD MILLION) 62

TABLE 63 EUROPE MASTITIS MARKET FOR BOVINE, BY TYPE 2020–2027 (USD MILLION) 62

TABLE 64 EUROPE MASTITIS MARKET FOR HUMAN, BY TYPE 2020–2027 (USD MILLION) 63

TABLE 65 EUROPE MASTITIS MARKET, BY TREATMENT 2020–2027 (USD MILLION) 63

TABLE 66 EUROPE MASTITIS MARKET FOR BOVINE, BY TREATMENT TYPE 2020–2027 (USD MILLION) 63

TABLE 67 EUROPE MASTITIS MARKET FOR HUMAN, BY TREATMENT TYPE 2020–2027 (USD MILLION) 63

TABLE 68 EUROPE MASTITIS MARKET, BY END–USER 2020–2027 (USD MILLION) 64

TABLE 69 WESTERN EUROPE MASTITIS MARKET, BY COUNTRY 2020–2027 (USD MILLION) 64

TABLE 70 WESTERN EUROPE MASTITIS MARKET, BY TYPE 2020–2027 (USD MILLION) 65

TABLE 71 WESTERN EUROPE MASTITIS MARKET FOR BOVINE, BY TYPE 2020–2027 (USD MILLION) 65

TABLE 72 WESTERN EUROPE MASTITIS MARKET FOR HUMAN, BY TYPE 2020–2027 (USD MILLION) 65

TABLE 73 WESTERN EUROPE MASTITIS MARKET, BY TREATMENT 2020–2027 (USD MILLION) 65

TABLE 74 WESTERN EUROPE MASTITIS MARKET FOR BOVINE, BY TREATMENT TYPE 2020–2027 (USD MILLION) 66

TABLE 75 WESTERN EUROPE MASTITIS MARKET FOR HUMAN, BY TREATMENT TYPE 2020–2027 (USD MILLION) 66

TABLE 76 WESTERN EUROPE MASTITIS MARKET, BY END–USER 2020–2027 (USD MILLION) 66

TABLE 77 GERMANY MASTITIS MARKET, BY TYPE 2020–2027 (USD MILLION) 67

TABLE 78 GERMANY MASTITIS MARKET FOR BOVINE, BY TYPE 2020–2027 (USD MILLION) 67

TABLE 79 GERMANY MASTITIS MARKET FOR HUMAN, BY TYPE 2020–2027 (USD MILLION) 67

TABLE 80 GERMANY MASTITIS MARKET, BY TREATMENT 2020–2027 (USD MILLION) 67

TABLE 81 GERMANY MASTITIS MARKET FOR BOVINE, BY TREATMENT TYPE 2020–2027 (USD MILLION) 68

TABLE 82 GERMANY MASTITIS MARKET FOR HUMAN, BY TREATMENT TYPE 2020–2027 (USD MILLION) 68

TABLE 83 GERMANY MASTITIS MARKET, BY END–USER 2020–2027 (USD MILLION) 68

TABLE 84 FRANCE MASTITIS MARKET, BY TYPE 2020–2027 (USD MILLION) 69

TABLE 85 FRANCE MASTITIS MARKET FOR BOVINE, BY TYPE 2020–2027 (USD MILLION) 69

TABLE 86 FRANCE MASTITIS MARKET FOR HUMAN, BY TYPE 2020–2027 (USD MILLION) 69

TABLE 87 FRANCE MASTITIS MARKET, BY TREATMENT 2020–2027 (USD MILLION) 69

TABLE 88 FRANCE MASTITIS MARKET FOR BOVINE, BY TREATMENT TYPE 2020–2027 (USD MILLION) 70

TABLE 89 FRANCE MASTITIS MARKET FOR HUMAN, BY TREATMENT TYPE 2020–2027 (USD MILLION) 70

TABLE 90 FRANCE MASTITIS MARKET, BY END–USER 2020–2027 (USD MILLION) 70

TABLE 91 UK MASTITIS MARKET, BY TYPE 2020–2027 (USD MILLION) 71

TABLE 92 UK MASTITIS MARKET FOR BOVINE, BY TYPE 2020–2027 (USD MILLION) 71

TABLE 93 UK MASTITIS MARKET FOR HUMAN, BY TYPE 2020&